Pharmacology, Toxicology and Pharmaceutical Science
Protein
80%
Branch Retinal Vein Occlusion
66%
Aflibercept
66%
Biological Marker
66%
Proteome
47%
Alzheimer Disease
33%
Central Retina Vein Occlusion
33%
Caveolin 1
33%
Dexamethasone
33%
Platelet Derived Growth Factor Receptor
33%
Western Blot
25%
Diseases
25%
Biological Product
13%
Multiple Sclerosis
13%
Transmission Electron Microscopy
11%
Nanoparticle
11%
Argon
10%
Landrace Pig
10%
Macular Edema
9%
Inflammation
9%
Clotiazepam
8%
Malignant Neoplasm
8%
Metabolic Disorder
8%
Degenerative Disease
8%
Pathophysiology
8%
Vasculotropin Receptor 2
6%
Heat Shock Protein
6%
Vasculotropin
6%
Salt Water
6%
Mild Cognitive Impairment
5%
Medicine and Dentistry
Branch Retinal Vein Occlusion
68%
Retina Vein Occlusion
62%
Protein
37%
Central Retinal Vein Occlusion
35%
Dexamethasone
33%
Bevacizumab
33%
Transthyretin
33%
Caveolin 1
33%
Platelet Derived Growth Factor Receptor
33%
Interleukin 18
33%
Intravitreal Implant
33%
Retina
26%
Implant
22%
Immunohistochemistry
15%
Therapeutic Procedure
13%
Argon
11%
Western Blot
9%
Ischemia
8%
Proteomics
8%
Serositis
8%
Vasculotropin
7%
Tandem Mass Tag
7%
Mass Spectrum
7%
Choroid
7%
down Regulation
6%
Vision
6%
Intravitreal Administration
5%
Upregulation
5%
Neuroscience
Retinal Vein Occlusion
100%
Protein
71%
Bevacizumab
33%
Dexamethasone
33%
Transthyretin
33%
Central Retinal Vein
33%
Caveolin 1
33%
Interleukin 18
33%
Immunohistochemistry
13%
Proteome
9%
Ischemia
8%
Cell Signaling
8%
Protein Expression
8%
Neurodegenerative Disorder
8%
Mass Spectrometry
7%
Proteomics
5%
Angiography
5%
